GSK3B and small cell lung carcinoma: A recent study showed that metformin could suppress PKA activity and induce the activation of its downstream effectors, such as synthase kinase 3β (GSK-3β), resulting in SCLC cell death by AMPK/PKA/GSK-3β axis mediated surviving degradation.48